advertisement
Abstract #24650 Published in IGR 11-4
Interventional procedures in glaucoma: resources and costs in five european countries
Lafuma A; Verboven Y; Darba J; Brueggenjuergen B; Gylee E; Berto PValue in Health 2009; 12: A460
OBJECTIVES: Despite increasing medical management of glaucoma, interventional procedures remain a substantial part. This study in 5 countries (France, Germany, Spain, Italy and England) aimed to estimate the annual number and costs of glaucoma operating procedures (surgery and laser). METHODS: Analysis of the available Diagnosis Related Groups (DRG) national health care databases was performed. Both inpatient stays and ambulatory care in hospitals were selected on the basis of specific DRG and diagnosis codes. Standard costs were applied. RESULTS: There are large variations in the number of glaucoma-related hospitalizations reported. Germany and France had the highest numbers at 46,191 and 19,784 respectively. England, Italy and Spain had 7,741, 4,135 and 2,210 stays annually in that order. Databases for Italy and Spain, however, were not nationally exhaustive. Of these figures, 26,827 procedures included combined cataract-glaucoma coding in Germany and 6,656 in France. These figures on in-hospital were over the last 3 year stable in Italy, France and England, Spain whereas there is an upward trend in Germany. Outpatient treatments were only reported in England, an additional 3,340 procedures. Severe or more complex procedures involving surgery account for an estimated 46%, 93%, 67%, 23%, 89% in Germany, France, England, Italy, and Spain respectively. The corresponding average costs are a1972, a1469, a2246, a1946, and a2683. Of these. Day-Hospitalization in Italy account for 37% at a cost of 1085a while stays of less than 2 days in France account for 49% of all severe cases at a cost of 1009a. Total cost estimates are estimated at 65 million a in Germany, 28 million a in France and 6 million (pounds) in England. CONCLUSIONS: Available national health care databases have different coding.. Cost among severe interventions are comparable across countries. Short length of stay DRGs have a lower cost. Further studies including outpatient settings are needed.
A. Lafuma. Cemka, Bg la reine, Hauts de SeineFrance.
Classification:
14 Costing studies; pharmacoeconomics
